The CDC’s healthy brain initiative aims to improve “understanding of brain health as a central part of public health practice” through education to health care providers and patients. The Pharmacy Times Cognitive Health Focus series offers pharmacists information to help them actively participate as members of the health care team in addressing brain health.
Practitioners can identify cognitive issues through performance-based screening tools, such as Mini-Cog and Mini-Mental State Examination, and technology, such as Cognivue Thrive. Cognitive issues such as dementia and associated behavioral and neuropsychiatric symptoms (eg, depression and hallucinations) are often treated with pharmacological therapies.Medications such as acetylcholinesterase inhibitors (AChEIs; eg, donepezil, galantamine, and rivastigmine) and N-methyl-D-aspartate receptor antagonists such as memantine are considered for the treatment of dementia.
Read more at: https://www.pharmacytimes.com/publications/issue/2020/december2020/consider-impact-of-certain-medications-on-brain-function